Literature DB >> 11981261

Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1.

Peter C Harris1.   

Abstract

Recent developments have helped elucidate the function of the autosomal dominant polycystic kidney disease proteins, polycystin-1 and polycystin-2, and have revealed the primary defect in autosomal recessive polycystic kidney disease, by positional cloning of the gene, PKHD1. Several studies demonstrating that polycystin-2 can act as a calcium-ion-permeable cation channel, and that polycystin-1 may be involved in regulating/localizing this channel, have provided compelling evidence of the function of these proteins. A role in regulating intracellular calcium levels seems likely, with the many cellular abnormalities associated with cystogenesis due to a disruption of calcium homeostasis. Improved mutation analysis in autosomal dominant polycystic kidney disease has led to the finding of genotype/phenotype correlations which could be related to possible cleavage of polycystin-1. A major recent breakthrough has revealed the primary defect in autosomal recessive polycystic kidney disease. Genetic analysis showed that the PCK rat model is orthologous to autosomal recessive polycystic kidney disease, and allowed the human gene, PKHD1, to be precisely localized and identified. PKHD1 is a large gene, encoding a protein, fibrocystin, of 4074 amino acids, which is predicted to have a large extracellular region, a single transmembrane domain and a short cytoplasmic tail. Fibrocystin may act as a receptor with critical roles in collecting-duct and biliary development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981261     DOI: 10.1097/00041552-200205000-00007

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  24 in total

1.  Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.

Authors:  Fangming Lin; Thomas Hiesberger; Kimberly Cordes; Angus M Sinclair; Lawrence S B Goldstein; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

2.  Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat.

Authors:  Susanne N E Boehn; Sonja Spahn; Sabine Neudecker; Andrea Keppler; Marie-Thérèse Bihoreau; Bettina Kränzlin; Priyanka Pandey; Sigrid C Hoffmann; Li Li; Vicente E Torres; Hermann-Josef Gröne; Norbert Gretz
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

Review 3.  Molecular views of Arf-like small GTPases in cilia and ciliopathies.

Authors:  Qing Zhang; Jinghua Hu; Kun Ling
Journal:  Exp Cell Res       Date:  2013-03-31       Impact factor: 3.905

Review 4.  Cyclic AMP-mediated cyst expansion.

Authors:  Darren P Wallace
Journal:  Biochim Biophys Acta       Date:  2010-11-28

Review 5.  Translational research in ADPKD: lessons from animal models.

Authors:  Hester Happé; Dorien J M Peters
Journal:  Nat Rev Nephrol       Date:  2014-08-19       Impact factor: 28.314

6.  Loss of polycystin-1 causes centrosome amplification and genomic instability.

Authors:  Lorenzo Battini; Salvador Macip; Elena Fedorova; Steven Dikman; Stefan Somlo; Cristina Montagna; G Luca Gusella
Journal:  Hum Mol Genet       Date:  2008-06-19       Impact factor: 6.150

7.  Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease.

Authors:  Bonnie L Blazer-Yost; Julie Haydon; Tracy Eggleston-Gulyas; Jey-Hsin Chen; Xiaofang Wang; Vincent Gattone; Vicente E Torres
Journal:  PPAR Res       Date:  2010-11-01       Impact factor: 4.964

8.  Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy.

Authors:  Madeline A Lancaster; Carrie M Louie; Jennifer L Silhavy; Louis Sintasath; Marvalyn Decambre; Sanjay K Nigam; Karl Willert; Joseph G Gleeson
Journal:  Nat Med       Date:  2009-08-30       Impact factor: 53.440

Review 9.  Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.

Authors:  Benjamin D Cowley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation.

Authors:  Huan Sun; Qing-Wei Li; Xiao-Yan Lv; Jian-Zhong Ai; Qiu-Tan Yang; Jing-Jing Duan; Guo-Hui Bian; Yan Xiao; Yi-Dong Wang; Zheng Zhang; Yu-Hang Liu; Rui-Zhi Tan; Yang Yang; Yu-Quan Wei; Qin Zhou
Journal:  Mol Biol Rep       Date:  2009-10-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.